Yang et al. [29] found that PTH (1–34) was a safe and effective to improve vertebral BMD at onset time, growth rate and range in the treatment of primary osteoporosis, which could increase the bone mass of patients and reduce the risk of fracture. This evidence concerns the gene PTH and osteoporosis.